Strongyloides stercoralis: Life Cycle, Pathogenesis, Treatment, and Laboratory Diagnosis

A man who left a tropical region forty years ago is admitted with pneumonia and a bloodstream infection with gut bacteria. He has just been started on steroids for another problem. His blood count shows a puzzling feature that was present for years: a mildly raised eosinophil count that no one had explained.

The cause of everything, the decades-long eosinophilia, the sudden pneumonia, and the gut bacteria in his blood, is a single worm he acquired four decades earlier and never cleared: Strongyloides stercoralis. The steroids removed the only thing keeping it in check, the worm multiplied inside him without any new exposure, and larvae carried gut bacteria into his lungs and blood.

This sequence is what makes Strongyloides different from almost every other intestinal worm. It can maintain itself in one person for decades through internal reinfection, it often causes only vague symptoms until then, and it can turn suddenly lethal when immunity is suppressed. Understanding the parasite means understanding that cycle.

General Characteristics

Strongyloides stercoralis is a small intestinal nematode, a roundworm, sometimes called the threadworm, although that name is also used loosely for other worms and is best avoided to prevent confusion with pinworm. It is found in warm, humid regions with poor sanitation across the tropics and subtropics, and it also persists in temperate areas among people who acquired it earlier in life.

Two features set it apart from the other soil-transmitted nematodes such as hookworm and Ascaris.

1. First, only the female is parasitic in humans, and she reproduces without a male by a process in which the eggs develop without fertilization.
2. Second, and more important, Strongyloides can complete its cycle entirely within one host through autoinfection, so the infection can sustain and even amplify itself without any new exposure from the environment. No other common human intestinal nematode does this to the same degree.

The parasite also has a free-living cycle in the soil, in which male and female worms live and reproduce outside a host.

This alternation between a parasitic cycle in humans and a free-living cycle in the soil is unusual among the intestinal worms and is a favorite examination point.

Morphology

Three forms matter for understanding the parasite and its diagnosis: two kinds of larva and the parasitic adult female.

1. The rhabditiform larva is the first-stage larva. It is the form usually found in the stool, which is a key diagnostic point, because most other intestinal nematodes are detected as eggs rather than larvae. The rhabditiform larva has a short mouth cavity and a prominent structure in the middle of its body used to identify it. It is the stage that must be distinguished from hookworm larvae, which are also occasionally seen in stool.
2. The filariform larva is the infective third-stage larva. It is longer and more slender, and it is the form that penetrates skin to begin infection. In autoinfection, the parasite converts to this infective filariform stage while still inside the host, which is the step that allows internal reinfection.
3. The parasitic adult female is a very small, slender worm that lives buried in the wall of the small intestine, where she lays her eggs. The eggs hatch within the intestine, so it is the hatched rhabditiform larvae, not eggs, that appear in the stool.

Because the eggs hatch inside the intestine and release larvae, the diagnostic stage in stool is the rhabditiform larva rather than an egg. This single fact separates Strongyloides from hookworm and the other soil-transmitted nematodes in the laboratory.

Life Cycle of Strongyloides stercoralis

Strongyloides has three interlocking cycles: a direct parasitic cycle, a free-living cycle in the soil, and an autoinfection cycle inside the host. The autoinfection cycle is what makes the parasite clinically dangerous.

The parasitic cycle begins when infective filariform larvae in the soil penetrate the skin, usually of the feet. They enter the bloodstream, travel to the lungs, break into the air spaces, are coughed up and swallowed, and reach the small intestine. There the larvae mature into parasitic adult females that burrow into the intestinal wall and lay eggs. The eggs hatch within the intestine, and the resulting rhabditiform larvae are passed in the stool to the outside.

In the free-living cycle, rhabditiform larvae passed in the stool develop in the soil into free-living adult males and females that reproduce, producing a new generation of larvae. Some of these become infective filariform larvae ready to penetrate the skin of the next host. This soil cycle lets the parasite persist and multiply in the environment.

The autoinfection cycle is the crucial difference. Instead of leaving the body, some rhabditiform larvae transform into infective filariform larvae while still inside the intestine. These larvae penetrate the intestinal wall or the skin around the anus and re-enter the body, travel through the lungs, and return to the intestine to mature. Because this happens without any new exposure, a single original infection can maintain itself for decades, which is why people can carry Strongyloides for forty years or more after leaving an area where it is found.

When the host's immunity is intact, autoinfection proceeds slowly and the parasite burden stays low. When immunity is suppressed, the rate of autoinfection rises sharply. Larvae are produced and reinvade in large numbers, the parasite burden climbs rapidly, and the infection escalates into hyperinfection and disseminated disease.

Pathogenesis

The damage caused by Strongyloides follows the path the larvae take through the body, and its severity depends on the rate of autoinfection.

At the skin, penetrating larvae cause a local itchy, sometimes serpentine rash. When larvae migrating during autoinfection penetrate the skin around the anus and trunk, they produce a rapidly moving, itchy track called larva currens, a feature fairly specific to Strongyloides.

In the lungs, migrating larvae break into the air spaces and cause irritation, cough, and wheezing. In heavy infection this becomes significant respiratory illness.

In the intestine, the adult females and the movement of larvae through the mucosa cause inflammation, abdominal pain, diarrhea, and, in heavy infection, malabsorption. Many people with a stable, low-burden infection have only mild or intermittent symptoms, and a persistently raised eosinophil count may be the only clue for years.

Hyperinfection and disseminated disease are the feared outcomes. When immunity is suppressed, most importantly by corticosteroids, and also by conditions such as infection with the virus HTLV-1, malnutrition, and some cancers, autoinfection accelerates. In hyperinfection, very large numbers of larvae migrate through the lungs and gut. In disseminated disease, larvae spread beyond this usual route to organs such as the brain, liver, and kidneys. As the larvae travel, they carry gut bacteria with them from the intestine into the bloodstream and other sites, so hyperinfection is frequently complicated by bloodstream infection and meningitis caused by intestinal bacteria. Untreated, hyperinfection has a very high fatality rate.

A critical clinical point follows from this. Corticosteroids are the single most important trigger of hyperinfection. Giving steroids to a person with an unrecognized chronic Strongyloides infection can convert a silent, decades-old infection into a fatal one. This is why screening for Strongyloides is recommended before starting steroids or other immunosuppression in anyone who may have been exposed.

Clinical Findings

The clinical picture ranges from no symptoms at all to overwhelming, fatal disease, depending on the parasite burden and the host's immunity.

Chronic, uncomplicated infection often causes:

• Intermittent abdominal pain, bloating, and diarrhea
• An itchy skin rash, including the moving track of larva currens
• Cough or wheezing during larval migration
• A raised eosinophil count, sometimes the only finding for years

Hyperinfection and disseminated disease, seen when immunity is suppressed, cause:

• Severe abdominal pain, profuse diarrhea, and intestinal bleeding or obstruction
• Cough, breathlessness, and respiratory failure as larvae flood the lungs
• Bloodstream infection and meningitis with gut bacteria carried by the larvae
• Spread of larvae to organs including the brain, liver, and kidneys
• A high risk of death without prompt treatment

An important and dangerous feature of hyperinfection is that the eosinophil count, usually raised in chronic infection, is often low or normal when the patient is on steroids, because steroids suppress eosinophils. A normal eosinophil count therefore does not rule out severe Strongyloides infection in an immunosuppressed patient.

Laboratory Diagnosis

Diagnosing Strongyloides is difficult because larval output in the stool is low and irregular, and a single routine examination misses many infections. The methods below are arranged from least to most sensitive.

Direct stool microscopy. Examination of a stool sample may show motile rhabditiform larvae. This is specific when larvae are seen, but the sensitivity of a single specimen is low because larvae are shed in small numbers and intermittently. Examining several specimens collected on different days improves detection. The larvae must be distinguished from hookworm larvae, which can appear if a stool sample is left standing and hookworm eggs hatch.

Larval concentration and culture methods. Because larvae are scarce, methods that concentrate or culture them are far more sensitive than a plain smear. The Baermann technique uses the tendency of live larvae to move toward warm water to collect them from a stool sample, and the Harada-Mori filter paper culture and agar plate culture allow larvae to grow and multiply so they can be found more easily. Agar plate culture is among the most sensitive microscopy-based methods, because migrating larvae leave visible tracks of bacterial growth across the plate. These larval-recovery methods are the preferred microscopy approach when Strongyloides is suspected.

Serology. Antibody detection by enzyme immunoassay is more sensitive than a single stool examination and is useful for screening, particularly before immunosuppression and in people with unexplained eosinophilia. Its limitations are that it can cross-react with other worm infections and that antibody may persist after treatment, so it is better for detecting exposure than for confirming cure.

Molecular methods. PCR on stool detects Strongyloides DNA with high specificity and is increasingly used in reference laboratories, though availability is limited.

A practical rule brings these together. Because a single stool examination is so often falsely negative, Strongyloides should not be excluded on one negative stool. In anyone with unexplained eosinophilia, a compatible history of exposure, or a plan to start steroids, a larval-recovery method or serology should be used rather than relying on routine microscopy.

Treatment

The drug of choice for Strongyloides infection is ivermectin, which is effective against the larvae and is used for both uncomplicated infection and hyperinfection. Albendazole is an alternative but is less effective than ivermectin.

The aim of treatment differs from that for most intestinal worms. Because Strongyloides sustains itself through autoinfection, the goal is complete eradication, not merely reducing the worm burden. If any parasites remain, autoinfection can rebuild the infection, so cure must be confirmed and treatment repeated if necessary.

In hyperinfection and disseminated disease, treatment is a medical emergency. Ivermectin is given and continued until larvae are cleared, any immunosuppression is reduced where possible, and the accompanying bloodstream infection or meningitis with gut bacteria is treated at the same time. Even with treatment, the fatality of hyperinfection remains high, which is why prevention through screening is so important.

The most effective preventive measure in clinical practice is to identify and treat chronic infection before immunosuppression. Screening people with a history of exposure, and treating those found positive, before starting corticosteroids or other immunosuppressive therapy prevents the conversion of silent infection into fatal hyperinfection. General prevention follows the same principles as for other soil-transmitted worms: sanitation, safe disposal of feces, and wearing footwear to avoid skin penetration by larvae in contaminated soil.

Where Students Actually Get Confused

1. "Strongyloides is diagnosed by finding its eggs in stool, like hookworm and Ascaris." No. The eggs of Strongyloides hatch inside the intestine, so the stage passed in the stool is the rhabditiform larva, not an egg. Finding larvae rather than eggs in a fresh stool sample is a key feature that separates Strongyloides from the other soil-transmitted nematodes.

2. "One negative stool examination rules out Strongyloides." It does not. Larval output is low and irregular, and a single routine stool examination misses many infections. Diagnosis requires examining several specimens, using a larval-recovery method such as the Baermann technique or agar plate culture, or using serology. Excluding the infection on one negative stool is a common and dangerous error.

3. "Autoinfection just means getting reinfected from the environment again." Autoinfection is internal. Rhabditiform larvae transform into infective filariform larvae inside the intestine and reinvade the same host without ever leaving the body. This is why a single infection can persist for decades with no new exposure, and why the infection can amplify itself when immunity falls.

4. "Steroids treat the inflammation, so they help a Strongyloides patient." Steroids are the opposite of helpful here. Corticosteroids are the single most important trigger of hyperinfection, because they suppress the immunity that holds autoinfection in check. Giving steroids to a person with unrecognized chronic Strongyloides can convert a silent infection into a fatal one, which is why screening before immunosuppression matters.

5. "A normal eosinophil count means the infection is not severe." Not in an immunosuppressed patient. Eosinophilia is common in chronic infection, but steroids suppress eosinophils, so the count is often normal or low precisely when the patient is at greatest risk of hyperinfection. A normal eosinophil count does not rule out severe disease in someone on steroids.

6. "Reducing the worm burden is enough, as with other intestinal worms." Because Strongyloides reproduces inside the host through autoinfection, any remaining parasites can rebuild the infection. The goal of treatment is complete eradication and confirmation of cure, not simply lowering the number of worms.

Key Exam Facts

How to Remember

Larvae, not eggs. The one laboratory fact that anchors Strongyloides is that you find larvae in the stool, not eggs, because the eggs hatch inside the gut. Pair this with the two larval names: rhabditiform is the one you find (diagnosis), filariform is the one that infects (penetration and autoinfection). Rhabditiform for reporting, filariform for infecting.

The steroid trap. Hold one clinical scenario firmly: a person with a silent, decades-old infection is given steroids, and the worm multiplies out of control. Steroids suppress both the immunity that restrains autoinfection and the eosinophils that would otherwise warn you. This single image links autoinfection, hyperinfection, the steroid trigger, and the falsely normal eosinophil count.

Larva currens runs. The skin sign of autoinfection is larva currens, and currens means running. Picture a fast-moving, itchy track as the larva runs under the skin. It is the visible sign that the parasite is reinfecting from within.

Eradicate, do not just reduce. For most worms you lower the burden. For Strongyloides you must clear it completely, because anything left behind reinfects the host through autoinfection. The aim is cure, not reduction.

References and Further Readings

1. Garcia, L. S. (2016). Diagnostic Medical Parasitology (6th ed.). ASM Press.
2. Procop, G. W., Church, D. L., Hall, G. S., Janda, W. M., Koneman, E. W., Schreckenberger, P. C., & Woods, G. L. (2017). Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th ed.). Wolters Kluwer.
3. Nutman, T. B. (2017). Human infection with Strongyloides stercoralis and other related Strongyloides species. Parasitology, 144(3), 263–273. https://doi.org/10.1017/S0031182016000834
4. Buonfrate, D., Requena-Mendez, A., Angheben, A., et al. (2013). Severe strongyloidiasis: a systematic review of case reports. BMC Infectious Diseases, 13, 78. https://doi.org/10.1186/1471-2334-13-78
5. CDC – DPDx: Strongyloidiasis. Centers for Disease Control and Prevention. https://www.cdc.gov/dpdx/strongyloidiasis/index.html
6. World Health Organization. (2017). Diagnostic methods for the control and elimination of the neglected tropical diseases. WHO.